Erba Diagnostics Inc (ERBA) financial statements (2020 and earlier)

Company profile

Business Address 2140 NORTH MIAMI AVENUE
MIAMI, FL 33127
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 344
Cash and cash equivalents 344
Receivables 876
Inventory, net of allowances, customer advances and progress billings 766
Inventory 766
Prepaid expense and other current assets0
Other current assets 10
Total current assets: 181817
Noncurrent Assets
Property, plant and equipment 222
Intangible assets, net (including goodwill) 555
Goodwill 333
Intangible assets, net (excluding goodwill) 112
Regulated entity, other noncurrent assets   0
Restricted cash and investments 000
Other noncurrent assets 00
Prepaid expense and other noncurrent assets0
Other undisclosed noncurrent assets 111
Total noncurrent assets: 888
TOTAL ASSETS: 262625
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 523
Accounts payable 223
Accrued liabilities 2  
Employee-related liabilities 0  
Debt  21
Deferred revenue and credits 0  
Other undisclosed current liabilities 133
Total current liabilities: 677
Noncurrent Liabilities
Long-term debt and lease obligation 2  
Long-term debt, excluding current maturities 2  
Liabilities, other than long-term debt 222
Deferred tax liabilities, net 111
Other liabilities 111
Other undisclosed noncurrent liabilities (2)  
Total noncurrent liabilities: 222
Total liabilities: 888
Stockholders' equity
Stockholders' equity attributable to parent 181816
Common stock 000
Additional paid in capital 545353
Accumulated other comprehensive loss (0)(0)(1)
Accumulated deficit (35)(36)(37)
Total stockholders' equity: 181816
TOTAL LIABILITIES AND EQUITY: 262625

Income statement (P&L) ($ in millions)

6/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Revenues 2655
Revenue, net 262819
Cost of revenue
(Cost of Goods and Services Sold)
 (14)(14)(10)
Other undisclosed gross profit  2314
Gross profit: 13149
Operating expenses (12)(13)(10)
Operating income (loss): 11(1)
Nonoperating expense (0)(0)(0)
Foreign currency transaction loss, before tax (0)  
Other nonoperating income (expense) (0)(0)0
Interest and debt expense  (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes  00
Income (loss) from continuing operations before income taxes: 11(1)
Income tax expense (0)(0)(0)
Net income (loss) available to common stockholders, diluted: 01(2)

Comprehensive Income ($ in millions)

6/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Net income (loss): 01(2)
Comprehensive income (loss): 01(2)
Comprehensive loss, net of tax, attributable to noncontrolling interest   (1)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)0 
Comprehensive income (loss), net of tax, attributable to parent: 01(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: